TCT-77 Initial and Mid-Term Angiographic Outcomes of Septal Channel Perforation Related to Retrograde Recanalization for Chronic Total Occlusions  by Tanaka, Hiroyuki et al.
Methods: From 105 patients (male gender 79%, age 61.611.0 years), the
angiographic grade and direction of collateral flow in 121 totally occluded vessels
was compared to the transluminal attenuation gradient of vessel distal to total
occlusion (TAGdistal) derived from 64-detector row CCTA. TAG is defined as the
linear gradient of luminal attenuation along coronary artery, and was validated
against angiographical stenosis and flow velocity in our previous study.
Results: TAGdistal increased consistently and significantly with the degree of
collateral flow, from -4.434.02 HU/mm for Rentrop score 0 to 0.821.08
HU/mm for Rentrop score 3 (p0.0001). TAGdistal was also significantly higher
in retrograde flow compared to anterograde collateral flow (-2.443.04 HU/mm
versus 1.332.59 HU/mm, p0.0001). The well-developed collateral vessel that
have Rentrop score 2 or 3, which was found in 42.1% (51/121), could be predicted
by the TAGdistal cutoff value of  -1.28 HU/mm with area under receiver
operating characteristic curve of 0.689, and with a sensitivity and specificity,
positive and negative predictive value of 86.3%, 47.1%, and 54.3%, 82.5%,
respectively.
Conclusions: As far as we know, this is the first study showing that CT can
evaluate coronary collateral flow. Using TAG method, CCTA appears to be able
to measure quantitatively the degree and direction of coronary collateral circula-
tion, and predict angiographically well developed collateral vessels. These
abilities of CCTA may be useful for evaluation of patients with complex coronary
artery disease.
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Background: Coronary CT angiography (CCTA) has been used to predict procedural
success of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO).
However, the role of CCTA on the procedural outcome has not been reported in a
large-scaled study. We investigated the impact of pre-procedural CCTA on the procedural
success of CTO PCI on a patient-basis.
Methods: We retrospectively compared 2,840 patients without pre-procedural CCTA (no
CCTA group) and 658 patients with CCTA (CCTA group) from e-CTO, a Korean
multicenter registry comprising 26 centers. Results were further confirmed in propensity-
matched subgroup (N1,316).
Results: CCTA groups were younger (62.110.6 vs. 63.111.2), more were
female (21.9% vs. 27.4%), more had CTO in right coronary artery (45.0% vs.
37.6%, p0.05), and more risk factors. These differences were eliminated after
matching of 21 variables. The unadjusted CTO PCI success rate was lower in
CCTA group compared to non CCTA group (83.4% vs. 75.2%), and it was
consistent in subgroup analyses by lesion location (LAD, 78.4% vs. 85.7%; LCX,
72.5% vs. 84.3%; RCA, 73.3% vs. 80.4%, p0.05). The use of pre-procedural
CCTA was related to 0.61-fold decrease of odds for procedural success (95%
confidence interval (CI)0.49-0.74, p0.001) in unadjusted model. This result
was confirmed in covariate-adjusted model (OR0.57, 95% CI0.45 – 0.71) and
in propensity-score matched model (OR0.61, 95% CI0.47 – 0.80, p0.001).
Conclusions: Pre-procedural CCTA did not show beneficial impact on the procedural
success of CTO PCI in our multicenter registry. Careful selection or sophisticated CCTA
analytic methods would be required to demonstrate the clinical role of pre-procedural CCTA
before CTO PCI.
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Background: Chronic total occlusions (CTO) are the final stage of coronary
atherosclerosis. Coronary arteries with CTO have shown large plaque burden and
negative remodeling of the occluded region and the segments located distal to the
occlusion. Lumen and plaque changes located distal to successfully re-canalized
CTO remain unknown at follow-up.
Methods: Ninety-one CTO successfully treated with drug-eluting stents in 86
patients underwent quantitative angiography at baseline and 12-18 months
follow-up. Thirty-one lesions were investigated with IVUS. All analyses were
performed after nitroglycerin. Angiographic changes of were assessed with
quantitative coronary angiography as differences in minimal, mean and maximal
lumen diameter (MinLD, MeanLD and MaxLD, respectively). Vessel remodeling
was assessed with IVUS as changes in lumen, plaque and vessel volume.
Results: At follow-up, MinLD increased 23.9% (from 0.880.32 to 1.090.35mm:
p0.01), MeanLD 16.4% (from 1.590.44 to 1.850.45mm; p0.01) and MaxLD
11.7% (from 2.390.67 to 2.670.70mm; p0.01). Lumen enlargement was greater in
non-restenotic lesions, small lumen area at baseline and low LDL-cholesterol levels
during the study period. By IVUS, lumen increased 26.9% (from 108.189.2 to
137.3115.3mm3; p0.01), vessel increased 12.1% (from 207.1170.2 to 232.2196.0
mm3; p0.01) and plaque tended to decrease (-3.9%, from 98.988.7 to 94.989.3
mm3; p0.07). Small lumen at baseline was related to greater lumen enlargement.
Conclusions: Distal segments to re-canalized CTO show a notable lumen and
vessel enlargement with a trend towards of mild plaque regression. Low
LDL-Cholesterol levels during the study increases lumen enlargement. Angio-
graphic lesions distal to CTO may change and stent implantation must be
discouraged.
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Background: Introduction The J-CTO score has been shown to predict successful
guidewire crossing within 30 minutes in percutaneous coronary intervention (PCI)
for chronic total occlusions (CTO) in a multicentre Japanese registry. Hypothesis
We assessed the hypothesis that the J-CTO score is a useful risk score for
the prediction of procedural failure of PCI for CTO in a different cohort of
patients.
Methods: Methods The study included all consecutive patients undergoing PCI
for CTO at 3 tertiary PCI centres between January 2004 and December 2011. The
J-CTO score assigns 1 point to each of the following: calcification, bending, blunt
stump, occlusion length 20 mm, and previously failed lesion and classifies
lesions as easy (score of 0), intermediate (score of 1), difficult (score of 2), and
“very difficult” (score of 3). A multivariable mixed effect logistic regression for
clustered data was used to assess the impact of J-CTO score on PCI failure. Model
calibration was assessed as difference between predicted probabilities with the
worst or best prognosis (PSEP). Areas under receiver-operating characteristic
curve (AUC) were computed.
Results: Results A total of 1261 patients, median age 63 yrs-old (25th-75th
percentile, 55-72), undergoing PCI for 1418 CTO were included. PCI failure
occurred in 410 (28.9%) lesions. Failure rate significantly increased with
increasing J-CTO score (13.6%, 24.7%, 37.0%, 44.8%, in the groups with J-CTO
score of 0, 1, 2, 3, respectively, p0.001). At multivariable logistic regression
J-CTO score was a significant predictor of failure (odds ratio 1.68, 95%
confidence interval (CI) 1.43-1.97, p0.001, for each unit increase in J-CTO
score). PSEP was 0.34 and 0.33 in a model containing J-CTO score only, or
containing J-CTO score in addition to clinical, procedural variables and vessel
site, respectively. The AUC of a model containing J-CTO score only was
significantly higher than AUC of a model containing J-CTO score in addition to
clinical, procedural variables and vessel site (0.77, 95% CI 0.75-0.80, vs. 0.71,
95% CI 0.69- 0.74, p0.001).
Conclusions: Conclusions The J-CTO score is an independent predictor of failure of PCI
for CTO and has a good predictive accuracy as stand-
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Background: Septal channel perforation occurs rarely in retrograde recanalization
via septal channel for chronic total occlusion (CTO) lesions. There has been little
data on mid-term angiographic outcomes of septal channel perforation.
Methods: Septal channel perforation with cardiac tamponade or spreading
myocardial blush was treated with coil or fat tissue to occlude, balloon dilatation
at the donor artery, and administration of protamine. Persistent septal channel
perforation into the ventricle and coronary sinus or of non-growing myocardial
blush was followed up by no treatment. We examined the angiographic outcome
of no treatment cases of septal channel perforation.
Results: Between October 2005 and December 2011, we performed the retrograde
approach in 465 patients with 484 CTO lesions. Of these, the septal channel was
used in 55.2% (267/484), and its in-hospital outcomes were no major adverse
cardiac events and 1 cardiac tamponade. The incidence of septal channel
perforation was 15.4% (41/267). In septal channel perforation cases, we used the
coil (n5), fat tissue (n2), balloon dilatation (n3), and protamine (n15). Of
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41 lesions, 22 lesions were followed without treatment. Angiographic character-
istics of septal channel perforation were Ellis class I (n14), class II (n2), and
class IIICS (n6). Septal channel perforation occurred in guidewire (n13),
balloon dilatation (n8), and microcatheter (n1). The angiographic follow up
rate was 81.8% (class I: n11, class II: n2, and class IIICS: n5). Persistent
septal channel perforation disappeared at follow up angiography in all lesions.
Conclusions: Persistent septal channel perforation into the ventricle and coronary sinus
or of non-spreading myocardial blush may have a good outcome.
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Background: The impact of successful chronic total occlusion (TO) recanalisation
and completeness of revascularisation after PCI on long-term survival remains
unsettled.
Methods: Within the All-Comers SYNTAX Trial (n2636), the PCI and CABG arms
were stratified by the presence of TOs and complete (CR) vs. incomplete (ICR)
revascularisation. Clinical outcomes (Kaplan-Meier) were analysed with log-rank and
Cox regression analyses.
Results: In the randomised population, recanalisation/bypass rates of 49.4% (PCI)
vs. 68.1% (CABG) were reported. In the All-Comers population, 840 patients
(PCI: 26.3%, CABG: 36.4%, p0.001) with 1007 TOs were identified. The
presence of TOs was significantly associated with less CR by PCI (CR: TO 34.3%,
non TO 59.8%, p0.001) and CABG (CR: TO 64.8%, non TO 69.8%, p0.048).
The presence of a TO was the strongest independent predictor of ICR after PCI
(Hazard Ratio [95% CI]: 2.85 [2.09, 3.87], p0.001). Regardless of the presence
of a TO in the PCI & CABG arms, CR (compared to ICR) was associated with
significant reductions in 4-year mortality, all-cause revascularisation, and
MACCE. Four-year stent thrombosis rates in the PCI arm were significantly lower
with CR (3.7%) vs. ICR (6.5%, p0.046), an effect that was more pronounced in
the TO group.
Conclusions: Within the PCI and CABG arms of the All-Comers SYNTAX Trial
– and specifically in all patients with TOs – whatever the acceptable threshold of
revascularisation is appropriate for an individual patient, the identification of ICR
(compared to CR) using the SYNTAX Trial definition identifies patients who have
an adverse longer-term prognosis.
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Background: Interventions on chronic total occlusions (CTO) demand expert operator
skills, longer procedural time and are more frequently associated with complications.
Current guidelines for percutaneous coronary interventions (PCI) for CTO are based on
small retrospective studies and expert consensus. Consequently, there is a necessity to
strengthen such a recommendation with more evidence. The aim of this study was to
report and describe prevalence, demographics, clinical characteristics, treatment decisions
and trends in reporting on CTO at the level of one whole nation using data from the
Swedish Coronary Angiography and Angioplasty Registry (SCAAR).
Methods: SCAAR contains data on all consecutive patients who undergoes coronary
angiography or PCI in Sweden since 1989. Diagnosis of CTO in SCAAR is based on two
variables. The first variable is PCI physician’s mandatory evaluation of whether the
treated occluded segment is more than three months old. The second variable is a
non-mandatory reporting of lesions % stenosis in coronary artery segments.
Results: In January 2012, the SCAAR registry consisted of 497,572 procedures
performed in 348,863 patients. In total, 29,571 patients with a CTO were identified. A
CTO was observed in 10.9% of all performed procedures. In patients with significant
coronary lesions, a CTO was seen in 15.9%. CTO patients had more cardiovascular risk
factors and more extensive coronary artery disease. The majority of CTO patients were
treated conservatively and PCI revascularization of CTO is performed only in 5.8% of all
procedures. Revascularized CTO patients were younger and had more severe symptoms
while CTO patients with diabetes and multivessel disease were more likely to be referred
to CABG.
Conclusions: SCAAR is the largest data base of CTO patients to date. CTO is a frequent
finding in patients undergoing coronary angiography in Sweden and the number of CTO
procedures has been constant over the last 13 years. SCAAR may be a valuable source of
relevant clinical data in the process of building the real world evidence for the guidelines
regarding the optimal treatment of CTO patients.
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Background: Periprocedual myocardial infarction (PMI) in percutaneous coronary
intervention was reported to associate with increased risk of death in long-term follow-up.
However, there is a paucity of information about PMI in patients undergoing percutaneous
coronary intervention for chronic total occlusion (CTO-PCI). In this study, we investi-
gated incidence, predictors of PMI and prognostic impact after CTO-PCI.
Methods: We reviewed our CTO-PCI database and examined the incidence of PMI in
patients who had attempted CTO recanalization between 2003 and 2009. PMI was defined as
an increase of CK or CK-MB level more than three times higher than normal limit in
measurement within 24 hours after index procedure. All cause mortality was estimated at 5
years (median: 2.5 years; interquartile range: 1.8 to 3.5 years) according to Kaplan-Meier
analysis.
Results: Nine hundred and forty-five patients underwent CTO-PCI (mean age 63	/ 10
years old; 89% male) were enrolled. Overall procedure success rate was 70%. PMI was
observed in 53 (5.6%) of all patients and occurred more in failed patients than in
successful patients (7.1% vs 5.0%, p0.2). PMI patients had significantly less prior
history of myocardial infarction and of PCI and less hypercholesterolemia. CTO lesions
related to PMI were located less frequently in-stent and more in the contest of multivessel
disease compared to lesions without PMI. At 5 years follow-up, patients with PMI showed
significant higher rate of mortality compared to that without (29% vs 9 %, p0.0006). At
multivariate analysis, PMI (HR: 2.95, 95%CI: 1.27 to 6.02, p0.014), age (HR: 1.09,
95%CI: 1.06 to 1.12, p0.0001), chronic kidney disease (HR: 4.47, 95%CI: 2.38 to 8.10,
p0.0001) and left ventricular ejection fraction (HR 0.94, 95%CI: 0.92 to 0.96,
p0.0001) were significant predictors of all cause mortality.
Conclusions: In our registry, PMI was observed in 5.6% of CTO-PCI. PMI was an
independent predictor of all cause mortality in long-term follow up. From these data, we
don’t determine if PMI is a marker of more advanced disease or a true causative factor.
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